WO2017081467A1 - Syringes and inserts for syringes - Google Patents

Syringes and inserts for syringes Download PDF

Info

Publication number
WO2017081467A1
WO2017081467A1 PCT/GB2016/053519 GB2016053519W WO2017081467A1 WO 2017081467 A1 WO2017081467 A1 WO 2017081467A1 GB 2016053519 W GB2016053519 W GB 2016053519W WO 2017081467 A1 WO2017081467 A1 WO 2017081467A1
Authority
WO
WIPO (PCT)
Prior art keywords
insert
syringe
diameter
tapered portion
barrel
Prior art date
Application number
PCT/GB2016/053519
Other languages
French (fr)
Inventor
Iden Shams
Original Assignee
Gbuk Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gbuk Group Limited filed Critical Gbuk Group Limited
Publication of WO2017081467A1 publication Critical patent/WO2017081467A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • A61M5/3134Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M5/344Constructions for connecting the needle, e.g. to syringe nozzle or needle hub using additional parts, e.g. clamping rings or collets
    • A61M5/345Adaptors positioned between needle hub and syringe nozzle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10Tube connectors; Tube couplings
    • A61M2039/1077Adapters, e.g. couplings adapting a connector to one or several other connectors

Definitions

  • the invention relates generally to syringes and inserts for syringes and has particular relevance in the field of syringes for small-dose enteral administration and inserts therefor.
  • Small bore connectivity in healthcare is the focus of much attention given the potential to misconnect intravenous, enteral and intrathecal administration lines.
  • An erroneous connection between a syringe and an incorrect administration route can cause harm to or even death of a patient This is particularly pertinent in neonatal healthcare where the incorrect administration of even a very small dose of medicine can have a catastrophic effect on the small body of a baby.
  • administration typically comprises a female fitting with a large internal bore, there are concerns with regard to the accuracy in delivery of small volumes (eg. 50-100 ⁇ ) of medication in light of the potential for the medication to occupy dead space within the bore of the female fitting. Inaccurate doses may be administered as a consequence.
  • small volumes eg. 50-100 ⁇
  • CN280818 Y ZOU
  • CN201744031 U Andon et aL
  • US2012/245564 Tekeste et aL
  • CN202982798 Hu
  • Applicant's own application GB2469328 Shams.
  • CN2808184Y, CN 201744031 U and CN202982798 all concern syringes comprising a mechanism for retracting a needle into the barrel of the syringe after use for safer disposal.
  • US2012/245564 describes a series of devices and connectors external to a Luer connection in an attempt to provide a unique fir for components and provide a system specific geometry for enteral, neuraxial and intravenous applications.
  • CB2469328 describes a non-Luer system for the connection of a syringe to accessories.
  • the invention provides a syringe comprising a barrel- a plunger which is, in use, at least partially located inside said barrel and moveable within it; and a tip; wherein the syringe further comprises an insert which, in use, is located at least partially within said tip, the insert comprising front and rear ends and a channel which extends therethrough; wherein the shape and size of the insert is such that the insert is retained in the tip via an interference fit
  • This configuration is particularly advantageous because it provides a syringe with an insert which more accurately delivers the contents of the syringe for small doses of medicament when the syringe is actuated.
  • the size of the channel of the insert which is smaller in comparison to the internal diameter of the tip, minimises the amount of dead space in which a medicament can collect in use. This is particularly useful where a small dose of medid ne is being administered because the medicine is less likely to collect in the tip of the syringe.
  • the interference fit minimises the risk of or prevents the misconnection of the syringe with an incorrect administration route.
  • the retention of the insert is maintained unless said insert is pushed inwards by a force sufficient to overcome said interference fit
  • a force sufficient to overcome the interference fit
  • the interference fit minimises the risk of the syringe delivering the contents of the barrel if the syringe is connected to a female type connection of an incorrect administration route.
  • the interference fit minimises the risk that an operator will continue to use the syringe.
  • the risk of misconnection to an incorrect administration route prior to use is minimised or avoided altogether because a critical failure of the syringe is reliably caused when an incorrect connection is attempted.
  • the overall safety of the syringe is thus improved, specifically avoiding misconnection prior to use.
  • the tip comprises a female connection fitting incorporating a bore and, in use, said insert extends at least partially into said bore.
  • This configuration is particularly advantageous because, if an operator attempts to incorrectly attach a female type connection fitting to the tip, the insert is pushed towards the barrel to overcome the interference fit As the Insert extends at least partially into the bore of the female connection fitting, the interference fit is swiftly and reliably overcome where an incorrect connection is attempted.
  • This configuration also improves the delivery of a medicine because the risk of the medicine accumulating in the bore of the fitting is minimised or prevented.
  • the front end of said insert comprises a tubular potion and the rear end comprises a tapered portion; wherein each of the tubular and tapered portions has an inner and outer diameter; and wherein the diameter of said tapered portion at its widest point is greater than the diameter of said tubular portion.
  • This configuration is particularly advantageous because it ensures that an effective and reliable interference fit is in place between the Insert and the barrel.
  • said interference fit is between the tapered portion of said insert and said barrel.
  • This configuration is particularly advantageous because the interference fit between the tapered portion of the insert and the barrel forms a fluid-tight seal around the circumference of the insert, which is retained unless the Insert is pushed towards the barrel.
  • the outer diameter of at least part of said tubular portion increases in diameter towards said tapered portion. An increase in diameter of at least part of the tubular portion towards the tapered portion ensures an effective interference fit
  • the inner diameter of at least part of said tubular portion decreases In diameter towards said tapered portion.
  • the inner diameter of at least part of said tapered portion decreases towards the inner diameter of said tubular portion. This configuration acts to funnel fluid initially contained in said barrel towards the tip.
  • the outer diameter of at least part of said tapered portion decreases towards the outer diameter of said tubular portion.
  • This configuration acts to improve the interference fit
  • said barrel and tip form a seat onto which the tapered portion of the insert sits in use.
  • the seat which is formed improves the fluid-tight seal-forming interference fit between the barrel and insert This configuration also prevents the insert from passing entirely through the tip.
  • said interference fit is between said seat and the tapered portion of said insert This configuration improves the fluid-tight seal between an outer surface of the insert and the barrel.
  • the insert is comprised of a material which is more rigid than the material from which said barrel is comprised.
  • the insert is comprised of a material which is more rigid than the material form which the barrel is comprised to ensure a sufficient degree of interference to generate the fit between the barrel and the tip.
  • the diameter of said channel is wider towards the rear end of the insert than towards said front end. This configuration is particularly advantageous because it minimises the amount of dead space at the rear end of the insert where contents of the barrel may collect and not be delivered.
  • the insert is formed of a single piece of plastics material.
  • This configuration is particularly advantageous because the structural integrity of the insert is improved, thereby minimising the risk that the function of the insert will be impaired as stresses and strains typically expected with the use of syringes are applied.
  • a single piece also minimises or prevents the risk of small parts passing through the tip and into an administration route which might cause serious harm to a patient
  • the invention provides a syringe tip insert, said insert comprising a tubular portion with an inner and an outer diameter; and a tapered portion at one extremity of said tubular portion with an inner and an outer diameter; a channel extending through both said tubular portion; wherein the outer diameter of at least part of said tubular portion increases in diameter towards said tapered portion.
  • This configuration is particularly advantageous because it provides a syringe tip insert which more accurately delivers the contents of a syringe when the syringe is actuated.
  • the size of the channel of the insert which is smaller in comparison to that of a syringe tip, minimises the amount of dead space in which a medicament can collect in use. This is particularly useful where a small dose of medicine is being administered.
  • the interference fit between the insert and a syringe minimises the risk of or prevents the misconnection of a syringe with an incorrect administration route.
  • a syringe tip comprises a female type connection at its second end
  • the interference fit minimises the risk of the syringe delivering its contents if the syringe is connected to the female type connection of an incorrect administration route.
  • the insert is pushed towards the barrel of a syringe, by, for instance, a female Luer connection of another administration route, the interference fit is overcome and the insert retreats into the barrel of the syringe. This action minimises the risk that an operator will continue to use a syringe if misconnected.
  • An increase in diameter of at Least part of the tubular portion towards the tapered portion ensures an interference fit between the insert and the syringe.
  • the inner diameter of at least part of said tubular portion decreases in diameter towards said tapered portion.
  • the inner diameter of said tapered portion decreases towards the inner diameter of said tubular portion.
  • the outer diameter of said tapered portion decreases towards the outer diameter of said tubular portion. This configuration acts to improve the interference fit between the insert and the syringe.
  • the insert is formed of a single piece of plastics material.
  • This configuration is particularly advantageous because the structural integrity of the insert is improved, thereby minimising the risk that the function of the insert will be impaired as stresses and strains typically expected with the use of syringes are applied.
  • a single piece also minimises or prevents the risk of small parts passing through the tip of a syringe and into an administration route which might cause serious harm to a patient grief Description of the Drawings In the drawings:
  • Figure 1A shows a schematic perspective view of a syringe of a preferred embodiment
  • Figure 1B shows a cross-sectional side view of an insert of a preferred embodiment
  • Figure 2 shows a cross-sectional side view of the syringe of Figure 1 B.
  • Figure 3 shows a cross-sectional side view of a preferred embodiment of a syringe comprising a female connection fitting.
  • Figure 4A shows a perspective view of an insert of a preferred embodiment
  • Figure 4B shows a perspective view of a syringe of a preferred embodiment
  • FIG. 1 A A preferred embodiment of a syringe is shown in Figure 1 A and is referenced generally as 10.
  • the syringe 10 comprises a barrel 11, a plunger 12, a tip 24 and an insert 13, which forms an interference fit with the barrel 11, and functions to improve the accuracy with which medicaments are delivered by minimising dead space at the fluid exit point of the syringe 10, whilst minimising the risk that the syringe 10 is misconnected to an erroneous administration route.
  • the barrel 11, which has at least one outer surface and at least one inner surface comprising a receptacle for a medicament further comprises a first end 14 and a second end 15 and a chamber 25.
  • the first end 14 is the end which is typically held by an operator during use and incorporates one or more flanges 16 which, in use, are held by the hand of an operator as pressure is applied to a top end 17 of the plunger 12.
  • the syringe 10 comprises a tip 24 at the second end 15 of the barrel 11. In use, medicine is expelled from the barrel 11 via the tip 24 as pressure is applied to the plunger 12. As pressure is applied to the top end 17 of the plunger, a projection 18 is pushed further inside the barrel 11 to displace the contained fluid.
  • the plunger 12 further comprises a seal 19 at a distal end 20 of the projection 18 to prevent fluid from travelling towards the first end 14 of the barrel 11 as the plunger 12 is pushed towards the second end 15.
  • the first end 14 of the barrel 11 incorporates an opening for receiving the projection 18 of the plunger.
  • the tip 24 may comprise a connection fitting 26, such as a female screw-type fitting to facilitate attachment of the syringe 10 to an administration route, such as enteral tubing leading to the stomach of a patient
  • the fitting 26 comprises a bore 27 (see Figure 3) which is in fluid connection with the barrel 11.
  • the barrel 11 and tip 24 are integrally formed, but in an alternative embodiment the tip 24 is a separate component which is attached to the barrel 11 prior to use.
  • the insert 13 which is shown more dearly in Figure IB, comprises a front end 21 and a rear end 22 and a channel or passage 23 which extends therethrough.
  • the insert 13 is positioned within the syringe 10 such that it is held and extends through the tip 24.
  • An interference, press or friction fit is achieved between the barrel 11 and insert 13.
  • an additional interference fit may be in place between the insert 13 and at Least part of the tip 24.
  • the size and shape of the insert 13 is such that the insert 13 forms an interference fit (press fit, friction fit or fluid tight junction) with an inner surface of the barrel 11.
  • a seat 28 or shoulders are formed within the barrel 11 by the reduction in diameter between the barrel 11 and the tip 24.
  • the interference fit is between the insert 13 and the seat 28 or shoulders of the barrel 11.
  • the smaller diameter of the channel 23 of the insert 13 compared to the inner diameter of the tip 24 improves the accuracy of delivery of small doses of medicines because the space in which fluid may collect and subsequently fail to be dispersed from the syringe 10, as an operator applies pressure to the plunger 12 is reduced or eliminated.
  • the insert 13 In use, if the insert 13 is pushed towards the barrel 11, i.e. towards the first end of the barrel 11, with a force sufficient to overcome the interference fit between the barrel 11 and the insert 13, the insert 13 retreats into the barrel 11 of the syringe 10 to prevent misconnection of the syringe 10 with an erroneous administration route.
  • the motion of pushing the connector onto the insert 13 will cause the interference fit between the insert 13 and barrel 11 to be broken and the insert 13 will subsequently retreat into the barrel 11.
  • the interference fit between the insert 13 and the barrel 11 is sufficient to prevent dislodging of the insert 13 unless the insert 13 is specifically pressed towards the first end 14 of the barrel 11. This allows an operator to use the syringe 10 with confidence, knowing that the interference fit will only be broken if an incorrect connection with another administration route is attempted.
  • Figure 2 shows a cross-sectional view from the side of the syringe 10 to show, in more detail, the difference in inner diameter of the barrel 11 and tip 24 and how the channel 23 of the insert 13 further reduces In diameter to improve the accuracy with which medidnes can be delivered.
  • a seat 28 is formed by the change in inner diameter of the barrel 11 and the tip 24.
  • the front end 21 of the insert 13 comprises a tubular portion and the rear end 22 of the insert 13 comprises a tapered portion.
  • the tapered portion in use, abuts against the seat to form the interference fit to stabilise the insert 13 and to prevent it from passing entirety through the tip 24.
  • the insert 13 is tapered towards the front end 21 to ensure that, as the insert 13 contacts the inner surface of the barrel 11, there is sufficient friction between the insert 13 and barrel 11 to establish the interference fit (in preferred embodiment a fluid tight junction) between the two components.
  • the rear end 22 of insert 13 comprises a portion of increased diameter and the tapering of the insert is stepped. However, tapering of the insert 13 may alternatively be consistent from the rear end 22 towards the front end 21.
  • the insert 13 is tapered over a plurality of stepped portions towards the front end 21.
  • the tubular and tapered portions each has an inner and outer diameter, wherein the diameter of the tapered portion at its widest point is greater than the diameter of the tubular portion.
  • the outer diameter of at least part of, and more preferably all of, the tubular portion increases in diameter towards the tapered portion.
  • the inner diameter of at least part of, and more preferably all of, the tubular portion decreases in diameter towards the tapered portion.
  • the inner diameter of at least part of, and more preferably all of, the tapered portion decreases towards the inner diameter of the tubular portion.
  • the outer diameter of at least part of, and more preferably all of, the tapered portion decreases towards the outer diameter of the tubular portion.
  • the outer diameter of the tubular portion of the insert 13 tapers such that the syringe 10 is incompatible with a female Luer connector, i.e. it is not a 6% taper.
  • the taper of the outer diameter of the tubular portion is between 1% and 4% and preferably the taper is 2%.
  • the diameter and taper of the bore of the tip 24 Is such that the tip 24 is incompatible with a male Luer connector. This is because the diameter of the bore of the tip 24 is much larger than the diameter of a male Luer connector.
  • the diameter of the channel 23 of the insert 13 is wider towards the rear end 22 of the insert 13 than towards the front end 21.
  • the wider diameter towards the rear end 22 improves the ability of the insert 13 to channel fluid from the barrel 11 out of the syringe 10 because the opportunity for fluid to collect around the rear end 22 of the insert 13 and not flow through the channel 23 is minimised.
  • the tip 24 incorporates a fitting 26 and the insert 13 extends at least partially into the bore 27 of the fitting 26 once an interference fit is established between the barrel 11 and the insert 13.
  • the insert 13 does not extend beyond the rim of the fitting 26 to minimise the risk that the insert 13 is knocked or pushed from the side, which might dislodge the Insert 13 during normal, correct use.
  • the insert 13 is comprised of a material which is more rigid than the material from which the barrel 11 is comprised.
  • the barrel 11 is preferably comprised polypropylene and the insert 13 is therefore preferably comprised of a material which is more rigid than polypropylene or is comprised of polypropylene which is more rigid than the polypropylene of the barrel 11.
  • the insert 13 is formed of a single piece. Being formed of a single piece, the insert can be more straightforwardly and reliably pushed inwards, towards the barrel, to prevent an incorrect and potentially unsafe connection to an erroneous administration route.
  • the insert 13 is formed of a single piece of plastics material.
  • the insert 13 is not necessarily form ed of a single piece of plastics material as shown in the figures, in an alternative embodiment at least a portion of the insert 13 is comprised of a material which is more flexible than the material of the barrel
  • the insert 13 is preferably removably inserted in said barrel 11 so that the insert 13 may be used with different syringes.
  • The may be provided as part of a kit with the syringe 10 as shown in Figures 1A, 2 and 4B.
  • the insert 13 is provided on its own, i.e. without the syringe 10, as shown in Figures 1 B and 4A.
  • the insert 13 forms an interference fit with a portion of a barrel, preferably of reduced diameter, of a separate syringe.
  • the syringes described may be of a non-needle bearing type or primarily used for the purposes of dosing contents into a tube or other feeding catheter. These embodiments may therefore be optionally referred to as non-needle bearing syringes.

Abstract

A syringe comprises a barrel; a plunger which Is, in use, at least partially located inside said barrel and moveable within it; and a tip; wherein the syringe further comprises an insert which, in use, is located at least partially within said tip, the insert comprising front and rear ends and a channel which extends therethrough; wherein the shape and size of the insert is such that the insert is retained in the tip via an interference fit

Description

Syringes and Inserts for Syringes
Field of the Invention
The invention relates generally to syringes and inserts for syringes and has particular relevance in the field of syringes for small-dose enteral administration and inserts therefor.
Background to the Invention
Small bore connectivity in healthcare is the focus of much attention given the potential to misconnect intravenous, enteral and intrathecal administration lines. An erroneous connection between a syringe and an incorrect administration route can cause harm to or even death of a patient This is particularly pertinent in neonatal healthcare where the incorrect administration of even a very small dose of medicine can have a catastrophic effect on the small body of a baby. Even where medid ne is correctly administered, it is important for uptake and delivery of a medicine to be accurate due to the small volume of the doses concerned.
In neonatal healthcare in particular, it is common practice to administer very small doses of medication via the enteral route. Given that the standard syringe used for
administration typically comprises a female fitting with a large internal bore, there are concerns with regard to the accuracy in delivery of small volumes (eg. 50-100μΙ) of medication in light of the potential for the medication to occupy dead space within the bore of the female fitting. Inaccurate doses may be administered as a consequence.
The following prior art is acknowledged: CN280818 Y (ZOU); CN201744031 U (Andon et aL); US2012/245564 (Tekeste et aL); CN202982798 (Hu); and the Applicant's own application GB2469328 (Shams). CN2808184Y, CN 201744031 U and CN202982798 all concern syringes comprising a mechanism for retracting a needle into the barrel of the syringe after use for safer disposal. US2012/245564 describes a series of devices and connectors external to a Luer connection in an attempt to provide a unique fir for components and provide a system specific geometry for enteral, neuraxial and intravenous applications. CB2469328 describes a non-Luer system for the connection of a syringe to accessories.
There is a real need to provide means for improving the accuracy with which small doses of medicament are delivered to a patient, and for minimising the risk of or preventing incorrect administration through misconnection of a syringe, prior to use of a syringe.
Summary of the Invention
In a broad independent aspect, the invention provides a syringe comprising a barrel- a plunger which is, in use, at least partially located inside said barrel and moveable within it; and a tip; wherein the syringe further comprises an insert which, in use, is located at least partially within said tip, the insert comprising front and rear ends and a channel which extends therethrough; wherein the shape and size of the insert is such that the insert is retained in the tip via an interference fit
This configuration is particularly advantageous because it provides a syringe with an insert which more accurately delivers the contents of the syringe for small doses of medicament when the syringe is actuated. The size of the channel of the insert, which is smaller in comparison to the internal diameter of the tip, minimises the amount of dead space in which a medicament can collect in use. This is particularly useful where a small dose of medid ne is being administered because the medicine is less likely to collect in the tip of the syringe. The interference fit minimises the risk of or prevents the misconnection of the syringe with an incorrect administration route. Preferably, the retention of the insert is maintained unless said insert is pushed inwards by a force sufficient to overcome said interference fit This configuration is particularly advantageous because the insert is dislodged if a force, sufficient to overcome the interference fit, is applied to the insert, i.e. the interference fit is overcome, if the insert is pushed inwards, towards the barrel For example, where the tip comprises a female type connection, the interference fit minimises the risk of the syringe delivering the contents of the barrel if the syringe is connected to a female type connection of an incorrect administration route. If the insert is pushed inwards, towards the barrel, by, for instance, a female Luer connection of another administration route, the interference fit is overcome and the insert is dislodged and withdraws into the barrel of the syringe, rendering the syringe ineffective or unusable. This action minimises the risk that an operator will continue to use the syringe. The risk of misconnection to an incorrect administration route prior to use is minimised or avoided altogether because a critical failure of the syringe is reliably caused when an incorrect connection is attempted. The overall safety of the syringe is thus improved, specifically avoiding misconnection prior to use.
Preferably, the tip comprises a female connection fitting incorporating a bore and, in use, said insert extends at least partially into said bore. This configuration is particularly advantageous because, if an operator attempts to incorrectly attach a female type connection fitting to the tip, the insert is pushed towards the barrel to overcome the interference fit As the Insert extends at least partially into the bore of the female connection fitting, the interference fit is swiftly and reliably overcome where an incorrect connection is attempted. This configuration also improves the delivery of a medicine because the risk of the medicine accumulating in the bore of the fitting is minimised or prevented.
Preferably, the front end of said insert comprises a tubular potion and the rear end comprises a tapered portion; wherein each of the tubular and tapered portions has an inner and outer diameter; and wherein the diameter of said tapered portion at its widest point is greater than the diameter of said tubular portion. This configuration is particularly advantageous because it ensures that an effective and reliable interference fit is in place between the Insert and the barrel.
Preferably, said interference fit is between the tapered portion of said insert and said barrel. This configuration is particularly advantageous because the interference fit between the tapered portion of the insert and the barrel forms a fluid-tight seal around the circumference of the insert, which is retained unless the Insert is pushed towards the barrel. Preferably, the outer diameter of at least part of said tubular portion increases in diameter towards said tapered portion. An increase in diameter of at least part of the tubular portion towards the tapered portion ensures an effective interference fit
Preferably, the inner diameter of at least part of said tubular portion decreases In diameter towards said tapered portion.
Preferably, the inner diameter of at least part of said tapered portion decreases towards the inner diameter of said tubular portion. This configuration acts to funnel fluid initially contained in said barrel towards the tip.
Preferably, the outer diameter of at least part of said tapered portion decreases towards the outer diameter of said tubular portion. This configuration acts to improve the interference fit Preferably, said barrel and tip form a seat onto which the tapered portion of the insert sits in use. The seat which is formed improves the fluid-tight seal-forming interference fit between the barrel and insert This configuration also prevents the insert from passing entirely through the tip. Preferably, said interference fit is between said seat and the tapered portion of said insert This configuration improves the fluid-tight seal between an outer surface of the insert and the barrel. Preferably, the insert is comprised of a material which is more rigid than the material from which said barrel is comprised. The insert is comprised of a material which is more rigid than the material form which the barrel is comprised to ensure a sufficient degree of interference to generate the fit between the barrel and the tip.
Preferably, the diameter of said channel is wider towards the rear end of the insert than towards said front end. This configuration is particularly advantageous because it minimises the amount of dead space at the rear end of the insert where contents of the barrel may collect and not be delivered.
Preferably, the insert is formed of a single piece of plastics material. This configuration is particularly advantageous because the structural integrity of the insert is improved, thereby minimising the risk that the function of the insert will be impaired as stresses and strains typically expected with the use of syringes are applied. A single piece also minimises or prevents the risk of small parts passing through the tip and into an administration route which might cause serious harm to a patient
In a second broad independent aspect, the invention provides a syringe tip insert, said insert comprising a tubular portion with an inner and an outer diameter; and a tapered portion at one extremity of said tubular portion with an inner and an outer diameter; a channel extending through both said tubular portion; wherein the outer diameter of at least part of said tubular portion increases in diameter towards said tapered portion. This configuration is particularly advantageous because it provides a syringe tip insert which more accurately delivers the contents of a syringe when the syringe is actuated. The size of the channel of the insert, which is smaller in comparison to that of a syringe tip, minimises the amount of dead space in which a medicament can collect in use. This is particularly useful where a small dose of medicine is being administered.
The interference fit between the insert and a syringe minimises the risk of or prevents the misconnection of a syringe with an incorrect administration route. For example, where a syringe tip comprises a female type connection at its second end, the interference fit minimises the risk of the syringe delivering its contents if the syringe is connected to the female type connection of an incorrect administration route. If the insert is pushed towards the barrel of a syringe, by, for instance, a female Luer connection of another administration route, the interference fit is overcome and the insert retreats into the barrel of the syringe. This action minimises the risk that an operator will continue to use a syringe if misconnected. An increase in diameter of at Least part of the tubular portion towards the tapered portion ensures an interference fit between the insert and the syringe.
Preferably, the inner diameter of at least part of said tubular portion decreases in diameter towards said tapered portion.
Preferably, the inner diameter of said tapered portion decreases towards the inner diameter of said tubular portion.
Preferably, the outer diameter of said tapered portion decreases towards the outer diameter of said tubular portion. This configuration acts to improve the interference fit between the insert and the syringe.
Preferably, the insert is formed of a single piece of plastics material. This configuration is particularly advantageous because the structural integrity of the insert is improved, thereby minimising the risk that the function of the insert will be impaired as stresses and strains typically expected with the use of syringes are applied. A single piece also minimises or prevents the risk of small parts passing through the tip of a syringe and into an administration route which might cause serious harm to a patient grief Description of the Drawings In the drawings:
Figure 1A shows a schematic perspective view of a syringe of a preferred embodiment
Figure 1B shows a cross-sectional side view of an insert of a preferred embodiment
Figure 2 shows a cross-sectional side view of the syringe of Figure 1 B.
Figure 3 shows a cross-sectional side view of a preferred embodiment of a syringe comprising a female connection fitting. Figure 4A shows a perspective view of an insert of a preferred embodiment Figure 4B shows a perspective view of a syringe of a preferred embodiment
Detailed Description of the Embodiments
A preferred embodiment of a syringe is shown in Figure 1 A and is referenced generally as 10. The syringe 10 comprises a barrel 11, a plunger 12, a tip 24 and an insert 13, which forms an interference fit with the barrel 11, and functions to improve the accuracy with which medicaments are delivered by minimising dead space at the fluid exit point of the syringe 10, whilst minimising the risk that the syringe 10 is misconnected to an erroneous administration route. The barrel 11, which has at least one outer surface and at least one inner surface comprising a receptacle for a medicament, further comprises a first end 14 and a second end 15 and a chamber 25. The first end 14 is the end which is typically held by an operator during use and incorporates one or more flanges 16 which, in use, are held by the hand of an operator as pressure is applied to a top end 17 of the plunger 12. The syringe 10 comprises a tip 24 at the second end 15 of the barrel 11. In use, medicine is expelled from the barrel 11 via the tip 24 as pressure is applied to the plunger 12. As pressure is applied to the top end 17 of the plunger, a projection 18 is pushed further inside the barrel 11 to displace the contained fluid. The plunger 12 further comprises a seal 19 at a distal end 20 of the projection 18 to prevent fluid from travelling towards the first end 14 of the barrel 11 as the plunger 12 is pushed towards the second end 15.
The first end 14 of the barrel 11 incorporates an opening for receiving the projection 18 of the plunger. The tip 24 may comprise a connection fitting 26, such as a female screw-type fitting to facilitate attachment of the syringe 10 to an administration route, such as enteral tubing leading to the stomach of a patient The fitting 26 comprises a bore 27 (see Figure 3) which is in fluid connection with the barrel 11. In a preferred embodiment, the barrel 11 and tip 24 are integrally formed, but in an alternative embodiment the tip 24 is a separate component which is attached to the barrel 11 prior to use.
The insert 13, which is shown more dearly in Figure IB, comprises a front end 21 and a rear end 22 and a channel or passage 23 which extends therethrough. In use, the insert 13 is positioned within the syringe 10 such that it is held and extends through the tip 24. An interference, press or friction fit is achieved between the barrel 11 and insert 13. In one embodiment, an additional interference fit may be in place between the insert 13 and at Least part of the tip 24. Once the Insert 13 is inserted and retained by the interference fit, the front end 21 of the insert 13 is preferably located beyond the tip 24, i.e. the front end 21 is located in the bore of the fitting 26. The size and shape of the insert 13 is such that the insert 13 forms an interference fit (press fit, friction fit or fluid tight junction) with an inner surface of the barrel 11. A seat 28 or shoulders are formed within the barrel 11 by the reduction in diameter between the barrel 11 and the tip 24. In a preferred
embodiment, the interference fit is between the insert 13 and the seat 28 or shoulders of the barrel 11.
The smaller diameter of the channel 23 of the insert 13 compared to the inner diameter of the tip 24 improves the accuracy of delivery of small doses of medicines because the space in which fluid may collect and subsequently fail to be dispersed from the syringe 10, as an operator applies pressure to the plunger 12 is reduced or eliminated.
In use, if the insert 13 is pushed towards the barrel 11, i.e. towards the first end of the barrel 11, with a force sufficient to overcome the interference fit between the barrel 11 and the insert 13, the insert 13 retreats into the barrel 11 of the syringe 10 to prevent misconnection of the syringe 10 with an erroneous administration route. For example, where an operator attempts to connect a female type connector to the syringe 10 and insert 13, the motion of pushing the connector onto the insert 13 will cause the interference fit between the insert 13 and barrel 11 to be broken and the insert 13 will subsequently retreat into the barrel 11. In a preferred embodiment the interference fit between the insert 13 and the barrel 11 is sufficient to prevent dislodging of the insert 13 unless the insert 13 is specifically pressed towards the first end 14 of the barrel 11. This allows an operator to use the syringe 10 with confidence, knowing that the interference fit will only be broken if an incorrect connection with another administration route is attempted.
Figure 2 shows a cross-sectional view from the side of the syringe 10 to show, in more detail, the difference in inner diameter of the barrel 11 and tip 24 and how the channel 23 of the insert 13 further reduces In diameter to improve the accuracy with which medidnes can be delivered.
Best shown in Figure 3, a seat 28 is formed by the change in inner diameter of the barrel 11 and the tip 24.
The front end 21 of the insert 13 comprises a tubular portion and the rear end 22 of the insert 13 comprises a tapered portion. In a preferred embodiment, the tapered portion, in use, abuts against the seat to form the interference fit to stabilise the insert 13 and to prevent it from passing entirety through the tip 24. In a further preferred embodiment, the insert 13 is tapered towards the front end 21 to ensure that, as the insert 13 contacts the inner surface of the barrel 11, there is sufficient friction between the insert 13 and barrel 11 to establish the interference fit (in preferred embodiment a fluid tight junction) between the two components. In one embodiment the rear end 22 of insert 13 comprises a portion of increased diameter and the tapering of the insert is stepped. However, tapering of the insert 13 may alternatively be consistent from the rear end 22 towards the front end 21. In another alternative embodiment, the insert 13 is tapered over a plurality of stepped portions towards the front end 21. In a preferred embodiment, the tubular and tapered portions each has an inner and outer diameter, wherein the diameter of the tapered portion at its widest point is greater than the diameter of the tubular portion. Preferably, the outer diameter of at least part of, and more preferably all of, the tubular portion increases in diameter towards the tapered portion. In a further preferred embodiment the inner diameter of at least part of, and more preferably all of, the tubular portion decreases in diameter towards the tapered portion. In a yet further preferred embodiment the inner diameter of at least part of, and more preferably all of, the tapered portion decreases towards the inner diameter of the tubular portion. In a still further preferred embodiment, the outer diameter of at least part of, and more preferably all of, the tapered portion decreases towards the outer diameter of the tubular portion.
In a preferred embodiment, the outer diameter of the tubular portion of the insert 13 tapers such that the syringe 10 is incompatible with a female Luer connector, i.e. it is not a 6% taper. In preferred embodiment, the taper of the outer diameter of the tubular portion is between 1% and 4% and preferably the taper is 2%.
In a preferred embodiment, the diameter and taper of the bore of the tip 24 Is such that the tip 24 is incompatible with a male Luer connector. This is because the diameter of the bore of the tip 24 is much larger than the diameter of a male Luer connector.
In a preferred embodiment, the diameter of the channel 23 of the insert 13 is wider towards the rear end 22 of the insert 13 than towards the front end 21. The wider diameter towards the rear end 22 improves the ability of the insert 13 to channel fluid from the barrel 11 out of the syringe 10 because the opportunity for fluid to collect around the rear end 22 of the insert 13 and not flow through the channel 23 is minimised.
In a preferred embodiment, where the tip 24 incorporates a fitting 26 and the insert 13 extends at least partially into the bore 27 of the fitting 26 once an interference fit is established between the barrel 11 and the insert 13. In a further preferred embodiment, which is shown in Figure 3, the insert 13 does not extend beyond the rim of the fitting 26 to minimise the risk that the insert 13 is knocked or pushed from the side, which might dislodge the Insert 13 during normal, correct use.
In a preferred embodiment, the insert 13 is comprised of a material which is more rigid than the material from which the barrel 11 is comprised. The barrel 11 is preferably comprised polypropylene and the insert 13 is therefore preferably comprised of a material which is more rigid than polypropylene or is comprised of polypropylene which is more rigid than the polypropylene of the barrel 11. In one embodiment, the insert 13 is formed of a single piece. Being formed of a single piece, the insert can be more straightforwardly and reliably pushed inwards, towards the barrel, to prevent an incorrect and potentially unsafe connection to an erroneous administration route. A critical failure of the syringe will occur if an incorrect administration route Is pushed onto the syringe tip and the single piece insert 13 improves the reliability with which the critical failure occurs. Devices comprising an insert having more than one piece would likely be less reliably pushed inwards when an erroneous connection is attempted. Preferably, the insert 13 is formed of a single piece of plastics material. The insert 13 is not necessarily form ed of a single piece of plastics material as shown in the figures, in an alternative embodiment at least a portion of the insert 13 is comprised of a material which is more flexible than the material of the barrel
In a preferred embodiment the insert 13 is preferably removably inserted in said barrel 11 so that the insert 13 may be used with different syringes. The may be provided as part of a kit with the syringe 10 as shown in Figures 1A, 2 and 4B. In an alternative, broad, embodiment the insert 13 is provided on its own, i.e. without the syringe 10, as shown in Figures 1 B and 4A. In this embodiment the insert 13 forms an interference fit with a portion of a barrel, preferably of reduced diameter, of a separate syringe.
In a further preferred embodiment the syringes described may be of a non-needle bearing type or primarily used for the purposes of dosing contents into a tube or other feeding catheter. These embodiments may therefore be optionally referred to as non-needle bearing syringes.

Claims

Claims 1. A syringe comprising a barrel;
a plunger which is, in use, at least partially located inside said barrel and moveable within it; and
a tip;
wherein the syringe further comprises an insert which, in use, is located at least partially within said tip, the insert comprising front and rear ends and a channel which extends therethrough;
wherein the shape and size of the insert is such that the insert is retained in the tip via an interference fit 2. A syringe according to claim 1, wherein the retention of the insert is maintained unless said insert is pushed inwards by a force sufficient to overcome said interference fit
3. A syringe according to either daim 1 or claim 2, wherein the tip comprises a female connection fitting incorporating a bore and, In use, said insert extends at least partially into said bore.
4. A syringe according to any of the preceding claims, wherein the front end of said insert comprises a tubular potion and the rear end comprises a tapered portion; wherein each of the tubular and tapered portions has an inner and outer diameter; and wherein the diameter of said tapered portion at its widest point is greater than the diameter of said tubular portion.
5. A syringe according to claim 4, wherein said interference fit is between the tapered portion of said insert and said barrel
6. A syringe according to either claim 4 or claim 5, wherein the outer diameter of at least part of said tubular portion increases in diameter towards said tapered portion.
7. A syringe according to any of claims 4 to 6, wherein the inner diameter of at least part of said tubular portion decreases in diameter towards said tapered portion.
8. A syringe according to any of claims 4 to 7, wherein the inner diameter of at least part of said tapered portion decreases towards the inner diameter of said tubular portion.
9. A syringe according to any of daims 4 to 8, wherein the outer diameter of at least part of said tapered portion decreases towards the outer diameter of said tubular portion.
10. A syringe according to any of daims 4 to 9, wherein said barrel and tip form a seat onto which the tapered portion of the insert sits in use.
11. A syringe according to daim 10, wherein said interference fit is between said seat and the tapered portion of said insert
12. A syringe according to any of the preceding daims, wherein the insert is comprised of a material which is more rigid than the material from which said barrel is comprised.
13. A syringe according to any of the preceding claims, wherein the diameter of said channel is wider towards the rear end of the insert than towards said front end.
14. A syringe according to any of the preceding claims, wherein the insert is formed of a single piece of plastics material.
15. A syringe substantially as hereinbefore described with reference to and as illustrated by the accompanying drawings.
16. A syringe tip insert, said insert comprising a tubular portion with an inner and an outer diameter; and a tapered portion at one extremity of said tubular portion with an inner and an outer diameter;
a channel extending through both said tubular portion and said tapered portion;
wherein the outer diameter of at least part of said tubular portion increases in diameter towards said tapered portion.
17. An insert according to claim 16, wherein the inner diameter of at least part of said tubular portion decreases in diameter towards said tapered portion.
18. An insert according to either claim 16 or claim 17, wherein the inner diameter of said tapered portion decreases towards the inner diameter of said tubular portion.
19. An insert according to any of claims 16 to 18, wherein the outer diameter of said tapered portion decreases towards the outer diameter of said tubular portion.
20. An insert according to any of claims 16 to 19, wherein the insert is formed of a single piece of plastics material.
21. An insert substantially as hereinbefore described with reference to and as illustrated by the accompanying drawings.
PCT/GB2016/053519 2015-11-10 2016-11-10 Syringes and inserts for syringes WO2017081467A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1519802.1A GB2544278B (en) 2015-11-10 2015-11-10 Syringes and inserts for syringes
GB1519802.1 2015-11-10

Publications (1)

Publication Number Publication Date
WO2017081467A1 true WO2017081467A1 (en) 2017-05-18

Family

ID=55132552

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2016/053519 WO2017081467A1 (en) 2015-11-10 2016-11-10 Syringes and inserts for syringes

Country Status (2)

Country Link
GB (1) GB2544278B (en)
WO (1) WO2017081467A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112312946A (en) * 2018-04-24 2021-02-02 W.L.戈尔及同仁股份有限公司 Medical delivery device with inhibited oxygen permeation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000041494A2 (en) * 1999-01-11 2000-07-20 Peter Balfour Dugmore Safety syringe assembly
WO2008136775A2 (en) * 2007-05-08 2008-11-13 Jun Piao Teng A safety syringe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2808184Y (en) * 2005-01-10 2006-08-23 邹纯平 Self-destroyed safety syringe
GB2469328A (en) * 2009-04-09 2010-10-13 Iden Shams Needle and syringe with a tapered connector
CN201744031U (en) * 2010-08-06 2011-02-16 上海康德莱企业发展集团有限公司 Disposable retractable syringe
US9433768B2 (en) * 2011-03-25 2016-09-06 Becton, Dickinson And Company Drug delivery connectors
CN202982798U (en) * 2012-11-08 2013-06-12 苏州市雅思精密模具有限公司 Disposable syringe

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000041494A2 (en) * 1999-01-11 2000-07-20 Peter Balfour Dugmore Safety syringe assembly
WO2008136775A2 (en) * 2007-05-08 2008-11-13 Jun Piao Teng A safety syringe

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112312946A (en) * 2018-04-24 2021-02-02 W.L.戈尔及同仁股份有限公司 Medical delivery device with inhibited oxygen permeation

Also Published As

Publication number Publication date
GB201519802D0 (en) 2015-12-23
GB2544278B (en) 2017-11-08
GB2544278A (en) 2017-05-17

Similar Documents

Publication Publication Date Title
JP6694501B2 (en) Dosage control joint for enteral fluid flow
CN102458521B (en) Mixing device with piston coupling arrangement
US5242423A (en) Needleless syringe
AU2013232259B2 (en) Fill-finish cartridges for sterile fluid pathway assemblies and drug delivery devices incorporating fill-finish cartridges
US20160361235A1 (en) Adapter assembly for enteral feeding
CN109789274B (en) Syringe with enteral connection
US7981089B2 (en) Vial access device
KR20100131450A (en) Syringe with recessed nose and protective guard for use with frontal attachments
GB2495492A (en) Syringe tip with non-luer fitting
KR20120120147A (en) Syringes
US11957863B2 (en) Luer having microbore tubing retention pocket bond with axial spline
US20120046618A1 (en) Needle and syringe
US20230201458A1 (en) Pressure indicator for medicament delivery device
US8491544B2 (en) Enteral feeding connector
KR20110003950A (en) A safety socket enabling to prevent medicine accident and an infusion bag kit including the socket
WO2017081467A1 (en) Syringes and inserts for syringes
US20200179596A1 (en) Fill-Finish Carriers For Drug Containers
AU2019250262A1 (en) Subcutaneous infusion device for injecting medicinal substances
CN216258585U (en) Syringe
ITMO20100306A1 (en) CONTAINER FOR MEDICAL SUBSTANCES

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16797611

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16797611

Country of ref document: EP

Kind code of ref document: A1